Ackman Claims 39% Support For Allergan Special Meeting

HFA Padded
Mark Melin
Published on
Updated on

William Ackman may now have enough votes to call a special Allergan, Inc. (NYSE:AGN) shareholder meeting in December, he said in a statement released Friday. It might now matter, says Allergan, as they are planning on holding a special shareholder meeting in December anyway. Allergan defending itself from Ackman and Valeant The game of tit for tat, that is the Allergan, Inc. (NYSE:AGN) fight to stave off acquisition by Ackman and Valeant Pharmaceuticals Intl Inc (NYSE:VRX), could result in some finality one way or another, before the end of the year.  On Friday Ackman announced he has the support of 39…

This content is exclusively for paying members of Hedge Fund Alpha

Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha

Don’t have an account?

Subscribe now and get 7 days free!
This article is only available for Premium Members
Subscribe today and get :
Insider Strategies and Letters to Shareholders from the Top Hedge Funds
Exclusive Access to coverage of Private, Closed-Door Investor Conferences
Hedge Fund Manager Research Currently Producing 21% – 40% Returns Annually

Don’t have an account?

Subscribe now and get 7 days free!
HFA Padded

Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.